How has the biocides industry managed the Covid-19 emergency so far?
Biocidal products are highly regulated in most parts of the world. This is because of the potential harm they present to human health and the environment, if manufactured, stored or used incorrectly. Yet the Covid-19 crisis has dramatically increased global demand for biocides. Over the course of an hour, this free webinar will look at industry’s efforts to ensure a continuing supply of disinfectants to help combat the coronavirus:
Speciality and intermediate chemical manufacturer Stepan produces active substances for biocides for many applications, including surface disinfectants. Speakers from the company will share issues facing the manufacturing industry at a global level, and discuss the impact of the current crisis on meeting the aims of the biocides regulations, fair competition and supply chains.
And Darren Abrahams, a partner at law firm Steptoe, will discuss the legal issues surrounding fast-tracking EU market access, including the future of current derogations and data rights issues.
- Darren Abrahams, partner, Steptoe & Johnson, Belgium
- Ken Littel, global regulatory affairs fellow, Stepan US, US
- Christophe Sene, global advisor for regulatory affairs, trade compliance and sustainability, Stepan Europe, France
If you can't attend the live broadcast, register for the webinar and you'll receive a link to the slides and recording once the webinar has finished.
If you have any further questions, email firstname.lastname@example.org.
For more on this topic, please join us on Wednesday 16 September for our Covid-19 Global Overview: Getting the right biocides to market virtual conference.